Second kidney transplant during childhood: clinical aspects, outcomes, and risk factors for graft survival

被引:0
|
作者
Feltran, Luciana de Santis [1 ]
Hamamoto, Fernando Kazuaki [1 ]
Genzani, Camila Penteado [1 ]
Fonseca, Mariana Janiques Barcia Magalhaes [1 ]
de Carvalho, Maria Fernanda Camargo [1 ]
Koch-Nogueira, Paulo Cesar [1 ,2 ]
机构
[1] Hosp Samaritano Sao Paulo, Pediat Kidney Transplantat Dept, Rua Tupi 535 7th Floor, BR-01233001 Sao Paulo, SP, Brazil
[2] Fed Univ Sao Paulo UNIFESP, Pediat Dept, Sao Paulo, Brazil
关键词
Kidney transplantation; Pediatrics; Retransplantation; Clinical aspects; RENAL-TRANSPLANTATION; SMALL CHILDREN; RETRANSPLANTATION; BASILIXIMAB; RECIPIENTS; BENEFIT;
D O I
10.1007/s00467-025-06685-6
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background The demand for kidney retransplants in the pediatric population is increasing as children are receiving their first transplants at a younger age. Methods This retrospective study included 51 children who underwent a second transplantation during childhood. We compared demographic and transplant characteristics, together with the clinical approach at the first and second transplants. Outcomes of second transplants were reported, and factors influencing repeat graft survival were investigated. Results Most of the children were male (69%), with congenital anomalies of the kidney and urinary tract as the primary cause of kidney failure (57%). Fifteen children (39%) weighing 20 kg or less underwent a second transplant. The leading cause of first graft loss was non-immunological (55%), being 27% vascular thrombosis. For the second transplantation, thymoglobulin, tacrolimus, and mycophenolate were preferred, with more frequent indications for anticoagulation prophylaxis. This approach was tailored to a significantly different clinical scenario: only 12% were susceptible to viral infections, and 59% were sensitized (PRA > 50%). After the second transplant, the patient survival rate was 100%, and the second allograft survival rates were 88% and 83% at 1 and 3 years, while after the first transplant, they were 94% and 91%, respectively. The proportional hazard model did not reveal any significant factors influencing the outcomes. Conclusions The clinical and immunological characteristics of children differed significantly between their first and second transplants, necessitating distinct medical approaches. Despite these challenges, pediatric kidney retransplantation seems to have a unique narrative and shows favorable outcomes, with high patient and graft survival rates, representing an effective treatment option.
引用
收藏
页码:2383 / 2391
页数:9
相关论文
共 50 条
  • [41] Poorer graft survival in ethnic minorities: results from a multi-centre UK study of kidney transplant outcomes
    Medcalf, J. F.
    Andrews, P. A.
    Bankart, J.
    Bradley, C.
    Carr, S.
    Feehally, J.
    Harden, P.
    Marsh, J.
    Newstead, C.
    Thompson, J.
    CLINICAL NEPHROLOGY, 2011, 75 (04) : 294 - 301
  • [42] Pre-transplant risk factors for tuberculosis after kidney transplant in an intermediate burden area
    Jung, J. Y.
    Joo, D. J.
    Lee, C-H.
    Park, M. S.
    Kim, Y. S.
    Kim, M. S.
    Kim, S. I.
    Kim, Y. S.
    Kim, S. K.
    Chang, J.
    Kang, Y. A.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2012, 16 (02) : 248 - 254
  • [43] Cytopenias in pediatric kidney transplant recipients: preceding factors and clinical consequences
    Regev-Sadeh, Shira
    Borovitz, Yael
    Steinberg-Shemer, Orna
    Gilad, Oded
    Shoham, Shoval
    Yacobovich, Joanne
    PEDIATRIC NEPHROLOGY, 2023, 38 (10) : 3445 - 3454
  • [44] Analysis of Risk Factors and Long-Term Outcomes in Kidney Transplant Patients with Identified Lymphoceles
    Lehner, Lukas J.
    Hohberger, Arnim
    Marschke, Lisanne
    Lachmann, Nils
    Peters, Robert
    Friedersdorff, Frank
    Khadzhynov, Dmytro
    Halleck, Fabian
    Budde, Klemens
    Staeck, Oliver
    Duerr, Michael
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (09) : 1 - 15
  • [45] Effect of Statins on Patients and Graft Survival in Kidney Transplant Recipients A Survival Meta-analysis
    Rostami, Zohre
    Arani, Mahdi Moteshaker
    Salesi, Mahmood
    Safiabadi, Mahdi
    Einollahi, Behzad
    IRANIAN JOURNAL OF KIDNEY DISEASES, 2017, 11 (05) : 329 - 338
  • [46] A Single-Center Experience With Third and Fourth Kidney Transplants and Second Kidney Transplant After Pancreas-Kidney Transplant Surgical Aspects and Outcomes
    Salguero Segura, Joseba
    Valero Rosa, Jose
    Gomez Gomez, Enrique
    Navarro Cabello, Maria Dolores
    Ruiz Garcia, Jesus
    Rodriguez Benot, Alberto
    Robles Garcia, Jose Enrique
    Requena Tapia, Maria Jose
    Campos Hernandez, Juan Pablo
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2020, 18 (02) : 149 - 152
  • [47] Roma ethnicity and clinical outcomes in kidney transplant recipients
    Molnar, Miklos Z.
    Langer, Robert M.
    Remport, Adam
    Czira, Maria E.
    Rajczy, Katalin
    Kalantar-Zadeh, Kamyar
    Kovesdy, Csaba P.
    Novak, Marta
    Mucsi, Istvan
    Rosivall, Laszlo
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2012, 44 (03) : 945 - 954
  • [48] Risk Factors of Graft Survival After Diagnosis of Post-kidney Transplant Malignancy: Using Cox Proportional Hazard Model
    Foroushani, Abbas Rahimi
    Salesi, Mahmoud
    Rostami, Zohreh
    Mehrazmay, Ali Reza
    Mohammadi, Jamile
    Einollahi, Behzad
    Eshraghian, Mohammad Reza
    IRANIAN RED CRESCENT MEDICAL JOURNAL, 2015, 17 (11)
  • [49] The Risk Factors and Clinical Outcomes in Hepatitis B Seropositive and Seronegative Renal Transplant Patients
    Tsai, Yu-Lien
    Chung, Meng-Hsuan
    Lin, Niang-Cheng
    Chen, Cheng-Yen
    Lin, Yao-Ping
    Tsai, Ming-Tsun
    Tsai, Hsin-Lin
    Chen, Yee-An
    Ou, Shuo-Ming
    Chu, Chi-Jen
    Wu, Tsai-Hung
    Tsai, Chang-Youh
    AMERICAN JOURNAL OF NEPHROLOGY, 2024, 55 (04) : 477 - 486
  • [50] Mucocutaneous Manifestations in Kidney Transplant Patients: Risk Factors
    El Arabi, Yasmina
    Hali, Fouzia
    Mahdar, Yasmine
    Zahid, Sophia
    Zamd, Mohamed Ali
    Chiheb, Soumiya
    Ramdani, Benyounes
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (03)